Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1984 Nov;46(2):495–500. doi: 10.1128/iai.46.2.495-500.1984

Colony-stimulating activity induced by synthetic muramyl peptides: variation with chemical structure and association with anti-infectious activity.

A Galelli, P Lefrancier, L Chedid
PMCID: PMC261561  PMID: 6334030

Abstract

The in vivo induction of colony-stimulating activity (CSA) by N-acetylmuramyl-L-alanine-D-isoglutamine has been demonstrated recently. In this study we increased our understanding of this property by testing muramyl peptides of several structures and activities for their capacity to induce CSA in vivo. A comparison of the anti-infectious and adjuvant activities of these molecules revealed no correlation between the capacities of these compounds to be adjuvant active and to induce CSA: all adjuvant-inactive compounds induced CSA, and certain adjuvant-active molecules did not induce CSA. In contrast, all anti-infectious compounds induced CSA, but the reverse was not true; some compounds devoid of anti-infection activity were able to induce CSA only if they were adjuvant active.

Full text

PDF
495

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam A., Ciorbaru R., Ellouz F., Petit J. F., Lederer E. Adjuvant activity of monomeric bacterial cell wall peptidoglycans. Biochem Biophys Res Commun. 1974 Feb 4;56(3):561–567. doi: 10.1016/0006-291x(74)90640-8. [DOI] [PubMed] [Google Scholar]
  2. Audibert F., Chedid L., Lefrancier P., Choay J., Lederer E. Relationship between chemical structure and adjuvant activity of some synthetic analogues of N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP). Ann Immunol (Paris) 1977 Apr-Jun;128C(3):653–661. [PubMed] [Google Scholar]
  3. Audibert F., Chédid L., Lefrancier P., Choay J. Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble components. Cell Immunol. 1976 Feb;21(2):243–249. doi: 10.1016/0008-8749(76)90053-8. [DOI] [PubMed] [Google Scholar]
  4. Audibert F., Parant M., Damais C., Lefrancier P., Derrien M., Choay J., Chedid L. Dissociation of immunostimulant activities of muramyl dipeptide (MDP) by linking amino-acids or peptides to the glutaminyl residue. Biochem Biophys Res Commun. 1980 Sep 30;96(2):915–923. doi: 10.1016/0006-291x(80)91442-4. [DOI] [PubMed] [Google Scholar]
  5. Azuma I., Sugimura K., Yamawaki M., Uemiya M., Kusumoto S., Okada S., Shiba T., Yamamura Y. Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds. Infect Immun. 1978 Jun;20(3):600–607. doi: 10.1128/iai.20.3.600-607.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bradley T. R., Metcalf D. The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci. 1966 Jun;44(3):287–299. doi: 10.1038/icb.1966.28. [DOI] [PubMed] [Google Scholar]
  7. Chedid L. A., Parant M. A., Audibert F. M., Riveau G. J., Parant F. J., Lederer E., Choay J. P., Lefrancier P. L. Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity. Infect Immun. 1982 Feb;35(2):417–424. doi: 10.1128/iai.35.2.417-424.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chedid L., Parant M., Parant F., Audibert F., Lefrancier F., Choay J., Sela M. Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)--poly(L-lysine) carrier. Proc Natl Acad Sci U S A. 1979 Dec;76(12):6557–6561. doi: 10.1073/pnas.76.12.6557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chedid L., Parant M., Parant F., Lefrancher P., Choay J., Lederer E. Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs. Proc Natl Acad Sci U S A. 1977 May;74(5):2089–2093. doi: 10.1073/pnas.74.5.2089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ellouz F., Adam A., Ciorbaru R., Lederer E. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun. 1974 Aug 19;59(4):1317–1325. doi: 10.1016/0006-291x(74)90458-6. [DOI] [PubMed] [Google Scholar]
  11. Galelli A., Chedid L. Modulation of myelopoiesis in vivo by synthetic adjuvant-active muramyl peptides: induction of colony-stimulating activity and stimulation of stem cell proliferation. Infect Immun. 1983 Dec;42(3):1081–1085. doi: 10.1128/iai.42.3.1081-1085.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Galelli A., Le Garrec Y., Chedid L., Lefrancier P., Derrien M., Level M. Macrophage stimulation in vitro by an inactive muramyl dipeptide derivative after conjugation to a multi-poly(DL-alanyl)-poly(L-lysine) carrier. Infect Immun. 1980 Apr;28(1):1–5. doi: 10.1128/iai.28.1.1-5.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Handman E., Burgess A. W. Stimulation by granulocyte-macrophage colony-stimulating factor of Leishmania tropica killing by macrophages. J Immunol. 1979 Mar;122(3):1134–1137. [PubMed] [Google Scholar]
  14. Hibberd A. D., Metcalf D. Proliferation of macrophage and granulocyte precursors in response to primary and transplanted tumors. Isr J Med Sci. 1971 Jan;7(1):202–210. [PubMed] [Google Scholar]
  15. Jormalainen S., Mozes E., Sela M. Genetic control of immune response. The dose of antigen given in aqueous solution is critical in determining which mouse strain is high responder to poly(LTyr, LGlu)-poly(LPro)--poly(LLys). J Exp Med. 1975 May 1;141(5):1057–1072. doi: 10.1084/jem.141.5.1057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Leclerc C. D., Audibert F. M., Chedid L. A., Deriaud E. J., Masihi N. K., Lederer E. Comparison of immunomodulatory activities in mice and guinea pigs of a synthetic desmuramyl peptidolipid triglymyc. Infect Immun. 1984 Mar;43(3):870–875. doi: 10.1128/iai.43.3.870-875.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lefrancier P., Derrien M., Jamet X., Choay J., Lederer E., Audibert F., Parant M., Parant F., Chedid L. Apyrogenic, adjuvant-active N-acetylmuramyl-dipeptides. J Med Chem. 1982 Jan;25(1):87–90. doi: 10.1021/jm00343a018. [DOI] [PubMed] [Google Scholar]
  18. Lefrancier P., Derrien M., Lederman I., Nief F., Choay J., Lederer E. Synthesis of some new analogs of the immunoadjuvant glycopeptide MDP (N-acetyl-muramyl-L-alanyl-D-isoglutamine). Int J Pept Protein Res. 1978 Apr;11(4):289–296. doi: 10.1111/j.1399-3011.1978.tb02851.x. [DOI] [PubMed] [Google Scholar]
  19. McNeill T. A., Fleming W. A. The relationship between serum interferon and an inhibitor of mouse haemopoietic colonies in vitro. Immunology. 1971 Nov;21(5):761–766. [PMC free article] [PubMed] [Google Scholar]
  20. McNeill T. A., Killen M. Hemopoietic colony-forming cell responses in mice infected with ectromelia virus. Infect Immun. 1971 Oct;4(4):323–330. doi: 10.1128/iai.4.4.323-330.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Merser C., Sinay P., Adam A. Total synthesis and adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun. 1975 Oct 27;66(4):1316–1322. doi: 10.1016/0006-291x(75)90503-3. [DOI] [PubMed] [Google Scholar]
  22. Metcalf D. Acute antigen-induced elevation of serum colony stimulating factor (CFS) levels. Immunology. 1971 Sep;21(3):427–436. [PMC free article] [PubMed] [Google Scholar]
  23. Pabst M. J., Cummings N. P., Shiba T., Kusumoto S., Kotani S. Lipophilic derivative of muramyl dipeptide is more active than muramyl dipeptide in priming macrophages to release superoxide anion. Infect Immun. 1980 Aug;29(2):617–622. doi: 10.1128/iai.29.2.617-622.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Parant M. A., Audibert F. M., Chedid L. A., Level M. R., Lefrancier P. L., Choay J. P., Lederer E. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs. Infect Immun. 1980 Mar;27(3):826–831. doi: 10.1128/iai.27.3.826-831.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Parant M., Damais C., Audibert F., Parant F., Chedid L., Sache E., Lefrancier P., Choay J., Lederer E. In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde. J Infect Dis. 1978 Sep;138(3):378–386. doi: 10.1093/infdis/138.3.378. [DOI] [PubMed] [Google Scholar]
  26. Quesenberry P., Morley A., Stohlman F., Jr, Rickard K., Howard D., Smith M. Effect of endotoxin on granulopoiesis and colony-stimulating factor. N Engl J Med. 1972 Feb 3;286(5):227–232. doi: 10.1056/NEJM197202032860502. [DOI] [PubMed] [Google Scholar]
  27. Schleifer K. H., Kandler O. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev. 1972 Dec;36(4):407–477. doi: 10.1128/br.36.4.407-477.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Shadduck R. K., Waheed A., Pigoli G., Boegel F., Higgins L. Fractionation of antibodies to L-cell colony-stimulating factor by affinity chromatography. Blood. 1979 Jun;53(6):1182–1190. [PubMed] [Google Scholar]
  29. Stanley E. R., Cifone M., Heard P. M., Defendi V. Factors regulating macrophage production and growth: identity of colony-stimulating factor and macrophage growth factor. J Exp Med. 1976 Mar 1;143(3):631–647. doi: 10.1084/jem.143.3.631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Stupp Y., Borek F., Sela M. Studies on the types of immune responses to synthetic antigens in guinea-pigs. Immunology. 1966 Dec;11(6):561–570. [PMC free article] [PubMed] [Google Scholar]
  31. Trudgett A., McNeill T. A., Killen M. Granulocyte-macrophage precursor cell and colony-stimulating factor responses of mice infected with Salmonella typhimurium. Infect Immun. 1973 Sep;8(3):450–455. doi: 10.1128/iai.8.3.450-455.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Wu M. C., Yunis A. A. Common pattern of two distinct types of colony-stimulating factor in human tissues and cultured cells. J Clin Invest. 1980 Mar;65(3):772–775. doi: 10.1172/JCI109726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. van 't Hull E., Schellekens H., Löwenberg B., de Vries M. J. Influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitro. Cancer Res. 1978 Apr;38(4):911–914. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES